UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in CYTK — Cytokinetics Inc
CIK 861177
NEW YORK, NY
Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$23,259,507
+$7,399,455 QoQ
Shares Held
273,031
+13.5% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. CYTK ranks #27 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,259,507 | 273,031 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $15,860,052 | 240,632 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $14,935,010 | 235,049 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $13,101,470 | 238,382 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,752,996 | 416,253 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,414,527 | 308,896 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $14,829,357 | 315,250 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,084,716 | 266,756 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,650,215 | 251,942 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,267,510 | 117,922 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,732,008 | 116,565 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,560,061 | 120,844 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,769,108 | 115,546 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,066,061 | 115,546 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,457,917 | 97,292 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,962,190 | 81,779 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,907,388 | 99,450 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,446,997 | 93,643 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,292,174 | 94,168 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,480,711 | 69,410 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,245,482 | 62,935 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,475,078 | 63,417 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,113,287 | 53,575 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $1,145,890 | 52,928 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,140,998 | 48,409 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $699,864 | 59,361 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||